Related Experiment Video
Updated: Jun 12, 2026
Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays
Published on: October 23, 2019
Identification of novel inhibitors for a low molecular weight protein tyrosine phosphatase via virtual screening
Kristoff T Homan1, Deepa Balasubramaniam, Adam P R Zabell
1Department of Biological Sciences and Purdue University Center for Cancer Research, Purdue University, 915 W. State Street, West Lafayette, IN 47907, United States.
Abstract:
The human cytoplasmic protein tyrosine phosphatase (HCPTP) has been identified as a potential target for inhibition in order to downregulate metastatic transformation in several human epithelial cancers such as breast, prostate and colon cancer. Docking with two scoring functions on both isoforms of HCPTP was employed as an initial virtual screen to identify potential inhibitors. Compounds identified as potential inhibitors via this in silico screen were subjected to kinetic analysis in order to validate their selection as improved inhibitors. Eleven compounds with IC50's of less than 100 microM were identified in a single concentration screen. Five of these compounds were determined to have an IC50 of less than 10 microM; however, all but one of these compounds inhibited via non-specific aggregation. The validated effective inhibitor, which is based on a naphthyl sulfonic acid, strongly resembles a previously synthesized rationally designed azaindole phosphonic acid. This similarity suggests subsequent inhibitor optimization based on this scaffold may generate effective inhibitors of HCPTP. The structural elements of the computationally identified inhibitors are discussed to analyze the combined use of rational design and virtual screening to reduce false negatives in the identification of multiple strong inhibitors of HCPTP.
Insights
Researchers identified potential inhibitors for human cytoplasmic protein tyrosine phosphatase (HCPTP), a target for reducing cancer metastasis. A naphthyl sulfonic acid derivative emerged as a promising lead compound for further optimization.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Human cytoplasmic protein tyrosine phosphatase (HCPTP) is implicated in metastatic transformation in epithelial cancers.
- Targeting HCPTP offers a strategy to downregulate cancer progression.
Purpose of the Study:
- To identify potential inhibitors of HCPTP using virtual screening and kinetic analysis.
- To explore the structural basis for HCPTP inhibition and guide future drug design.
Main Methods:
- In silico virtual screening employing molecular docking with two scoring functions on HCPTP isoforms.
- Kinetic analysis to validate identified inhibitors and determine IC50 values.
- Structural analysis of validated inhibitors to understand structure-activity relationships.
Main Results:
- Eleven compounds showed IC50 values below 100 microM; five were below 10 microM.
- Most potent compounds exhibited non-specific inhibition via aggregation, except for one.
- A validated inhibitor, a naphthyl sulfonic acid derivative, showed structural similarity to a rationally designed azaindole phosphonic acid.
Conclusions:
- Virtual screening and kinetic analysis effectively identified HCPTP inhibitors.
- A naphthyl sulfonic acid scaffold shows potential for developing effective HCPTP inhibitors.
- Combining rational design with virtual screening can enhance the identification of potent inhibitors and reduce false negatives.
Related Concept Videos
02:04Protein-protein Interfaces
02:54Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...